Novem’s Post

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million patients in England alone! 😱 This surge has posed significant challenges for pharmaceutical companies in ensuring patient access to medicines across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we’re making a difference? 🤔 Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes, here 👉 https://lnkd.in/edpKraa9 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS

Ever wonder what a PBM does? Or what they are? Don't worry, we have you covered! Check out my podcast where we explain the lay of the land for PBM and PBM contracting.

I am pleased to have participated in the 7th National Pharmaceutical Conference, held on April 12-13. During the conference, I presented three key topics crucial to the health environment. 1. “Social Pharmacy, Role, and Importance in Healthcare”: In this presentation, we thoroughly examined the role and impact of social pharmacy in healthcare. We discussed strategies to improve patient access to medications and promote a more holistic and personalized care approach. 2. “Drug Interactions in Diabetic Patients”: Another topic we addressed was drug interactions in diabetic patients, emphasizing the importance of careful and personalized management of their therapy to minimize risks and optimize health outcomes. 3. “Evaluation of Drug Prescription Models Based on World Health Organization Indicators”: Finally, we analyzed current drug prescription models, focusing on WHO indicators. We discussed the advantages and challenges of these models and identified opportunities for improvement. This conference served as an important platform for knowledge exchange and influencing the development of the pharmaceutical field to ensure better healthcare for all. #Pharmacy #Healthcare #PharmaceuticalConference7 #Albania

In this episode of Wiley’s Health Care Contracting Chronicles, hosts Jordan A. Ross and Brooke M. DeLoatch introduce the complex world of PBMs and their pivotal role in the healthcare industry. They explore the functions of PBMs as intermediaries between insurers, pharmaceutical companies, and pharmacies, detailing their responsibilities in managing drug benefits and negotiating prices. The discussion also addresses the growing concerns around transparency and regulatory oversight, highlighting recent legislative efforts aimed at reforming PBM practices. Tune in to gain foundational insights into the PBM landscape and what it means for healthcare contracting in the future. https://lnkd.in/gh8H6r49 #PBM #Healthcare

Who is ready to discuss the trends in Patient Services for 2024? CareMetx surveyed providers and manufacturers to understand where we have made strides, and where there is still a ways to go. Increasing patient satisfaction emerged as the most important business objective for the pharmaceutical manufacturers and HCPs surveyed. Providing better support across the patient journey ranked close behind. Check out the full report here:  Elizabeth Kanter Eliza Silvester Elizabeth Pinto Tanya Carro https://lnkd.in/gNQN3BrS

📊 Overcome Copay Accumulator Challenges & Maximize Patient Access! Download Report Summary ➡️ https://buff.ly/49xzUeH In today's healthcare landscape, copay accumulator programs are driving up out-of-pocket costs, posing barriers to essential prescription treatments. As market dynamics shift and regulatory changes like the Inflation Reduction Act (IRA) take effect, pharmaceutical companies must reevaluate their copay accumulator mitigation strategies to ensure patient access and adherence. Based on insights from 25 Market Access and Patient Support executives, our client-based research unveils key KPIs for measuring copay accumulator mitigation program performance. Top metrics include the number of impacted patients (75%), out-of-pocket costs (67%), and adherence rates (54%). Discover the most effective tactics and strategies for mitigating copay accumulator impacts in our comprehensive report summary: https://buff.ly/49xzUeH #CopayAccumulatorPrograms #MarketAccess #PatientSupport #HealthcareAccess #BestPracticesLLC

Join us for our upcoming Q2 Pharmacy Webinar MedOne Pharmacy Benefit Solutions. We're thrilled to delve into the hottest topics shaping today's pharmaceutical landscape. Here's a sneak peek at what's on the agenda: Exploring Weight Loss Medications: Uncover the latest insights on coverage trends and effectiveness surrounding weight loss medications. We'll decode the nuances and discuss potential future developments. Navigating Patient Assistance Programs: Dive into the world of manufacturer patient assistance programs. We'll discuss shifts in strategy and their implications for patients and healthcare providers alike. Insights into Drug Shortages: Stay ahead of the curve with a comprehensive update on current drug shortages and their direct impact on patient care. Our experts will shed light on challenges and offer actionable solutions. These questions are just the beginning! Register now to join the conversation and gain invaluable insights into the evolving pharmacy landscape. REGISTER: https://lnkd.in/gJZqrjiv

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS 

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS

🚨 A House Oversight report finds that Pharmacy Benefit Managers (PBMs) prioritize higher-priced medicines when lower-cost options are available for patients - leading to higher costs for patients and the healthcare system. Combined with today's hearing on accountability and transparency for PBMs, this report marks a significant moment in time for drug manufacturers to illustrate how patients benefit from the medicines they develop. 💊 The pharmaceutical industry has an opportunity to lift patient stories to highlight the real-world personal impact of their products in the media, on social media, and through digital promotion. Patient stories resonate emotionally with audiences, fostering empathy and understanding while emphasizing the significance of innovation in healthcare. By sharing authentic narratives, patients can effectively convey the benefits of treatments. Companies should highlight medical advancements and demonstrate their commitment to these patients. https://lnkd.in/gnDm2wUn